The skyrocketing popularity of weight-loss drugs is fast becoming a state budgetary concern. Policymakers must choose between ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

The National Bariatric Center (NBC) of the Qatar Metabolic Institute (QMI) at Hamad Medical Corporation (HMC) has earned ...

“They have no nutritional value ... Small amounts of trans fats can increase the risk for cardiovascular disease significantly,” says Dr. Lopez-Jimenez. “They usually come in the form of partially ...

The “Plant, Pick & Plate Program” teaches children in southeast Fort Wayne hands-on gardening and cooking skills through ...

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

Waist circumference and waist-to-hip ratio show stronger links to colorectal cancer (CRC) than body mass index (BMI), a new ...